Piperazine → HCID 21891585, 화합물

반응식

[CH3:1][N:2]1[C:10]2[C:5](=[C:6]([O:15][CH3:16])[C:7]([O:13][CH3:14])=[C:8]([O:11][CH3:12])[CH:9]=2)[CH:4]=[C:3]1[C:17]([OH:19])=O.[NH:20]1[CH2:25][CH2:24][NH:23][CH2:22][CH2:21]1>>[CH3:1][N:2]1[C:10]2[C:5](=[C:6]([O:15][CH3:16])[C:7]([O:13][CH3:14])=[C:8]([O:11][CH3:12])[CH:9]=2)[CH:4]=[C:3]1[C:17]([N:20]1[CH2:25][CH2:24][N:23]([C:17]([C:3]2[N:2]([CH3:1])[C:10]3[C:5]([CH:4]=2)=[C:6]([O:15][CH3:16])[C:7]([O:13][CH3:14])=[C:8]([O:11][CH3:12])[CH:9]=3)=[O:19])[CH2:22][CH2:21]1)=[O:19]

참가 물질

반응물 2

HCID 4837Piperazine

HCID 907320HCID 907320, 화합물

생성물 1

HCID 21891585HCID 21891585, 화합물

실험 절차

N-Methyl-4,5,6-trimethoxyindole-2-carboxylic acid (200 mg) and piperazine (35 mg) were reacted in the same manner as in Preparation Example 37 to obtain the title compound.

출처 및 근거

ORD 기록: ord-ded416e90d214534bb55aeb654335c1b
출처 데이터셋: uspto-grants-2003_10
DOI: 10.6084/m9.figshare.5104873.v1
특허 번호: US06632810B2

반응 노트

불러오는 중…